The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
NAD + Metabolism in Cardiac Health, Aging, and Disease
Abstract
Nicotinamide adenine dinucleotide (NAD + ) is a central metabolite involved in energy and redox homeostasis as well as in DNA repair and protein deacetylation reactions. Pharmacological or genetic inhibition of NAD + -degrading enzymes, external supplementation of NAD + precursors, and transgenic overexpression of NAD + -generating enzymes have wide positive effects on metabolic health and age-associated diseases. NAD + pools tend to decline with normal aging, obesity, and hypertension, which are all major risk factors for cardiovascular disease, and NAD + replenishment extends healthspan, avoids metabolic syndrome, and reduces blood pressure in preclinical models. In addition, experimental elevation of NAD + improves atherosclerosis, ischemic, diabetic, arrhythmogenic, hypertrophic, or dilated cardiomyopathies, as well as different modalities of heart failure. Here, we critically discuss cardiomyocyte-specific circuitries of NAD + metabolism, comparatively evaluate distinct NAD + precursors for their preclinical efficacy, and raise outstanding questions on the optimal design of clinical trials in which NAD + replenishment or supraphysiological NAD + elevations are assessed for the prevention or treatment of major cardiac diseases. We surmise that patients with hitherto intractable cardiac diseases such as heart failure with preserved ejection fraction may profit from the administration of NAD + precursors. The development of such NAD + -centered treatments will rely on technological and conceptual progress on the fine regulation of NAD + metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats
Braidy, N., Guillemin, G. J., Mansour, H., Chan-Ling, T., Poljak, A., & Grant, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019194 · Cited by 594
RetractedDose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
The AIM-HIGH Investigators (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107579 · Cited by 2,911
Sirtuins as regulators of metabolism and healthspan
Houtkooper, R. H., Pirinen, E., & Auwerx, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3293 · Cited by 2,008
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin
Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824
Effects of extended-release niacin with laropiprant in high-risk patients
The HPS2-THRIVE Collaborative Group (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1300955 · Cited by 1,668
NAD+ metabolism and its roles in cellular processes during ageing
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00313-x · Cited by 1,617
Matsui, Y., Takagi, H., Qu, X., Abdellatif, M., Sakoda, H., Asano, T., Levine, B., & Sadoshima, J. (2007) · Circulation Research · doi:10.1161/01.res.0000261924.76669.36 · Cited by 1,505
Self-citationGomes, A. P., Price, N. L., Ling, A. J. Y., Moslehi, J. J., Montgomery, M. K., Rajman, L., White, J. P., Teodoro, J. S., Wrann, C. D., Hubbard, B. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.037 · Cited by 1,482
Cardiac Energy Metabolism in Heart Failure
Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R., & Abel, E. D. (2021) · Circulation Research · doi:10.1161/circresaha.121.318241 · Cited by 1,373
Fatkin, D., MacRae, C., Sasaki, T., Wolff, M. R., Porcu, M., Frenneaux, M., Atherton, J., Vidaillet, H. J., Spudich, S., De Girolami, U., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412302 · Cited by 1,359
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340
NAD + repletion improves mitochondrial and stem cell function and enhances life span in mice
Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255
Cantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
Mouchiroud, L., Houtkooper, R. H., Moullan, N., Katsyuba, E., Ryu, D., Cantó, C., Mottis, A., Jo, Y.-S., Viswanathan, M., Schoonjans, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.016 · Cited by 1,210
Circadian Control of the NAD + Salvage Pathway by CLOCK-SIRT1
Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M., & Sassone-Corsi, P. (2009) · Science · doi:10.1126/science.1170803 · Cited by 1,198
Dynamics of Cell Generation and Turnover in the Human Heart
Bergmann, O., Zdunek, S., Felker, A., Salehpour, M., Alkass, K., Bernard, S., Sjostrom, S. L., Szewczykowska, M., Jackowska, T., dos Remedios, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.026 · Cited by 1,133
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
Yoshino, J., Baur, J. A., & Imai, S.-I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.002 · Cited by 1,061
Nitrosative stress drives heart failure with preserved ejection fraction
Schiattarella, G. G., Altamirano, F., Tong, D., French, K. M., Villalobos, E., Kim, S. Y., Luo, X., Jiang, N., May, H. I., Wang, Z. V., et al. (2019) · Nature · doi:10.1038/s41586-019-1100-z · Cited by 951
Mills, K. F., Yoshida, S., Stein, L. R., Grozio, A., Kubota, S., Sasaki, Y., Redpath, P., Migaud, M. E., Apte, R. S., Uchida, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.013 · Cited by 930
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.003 · Cited by 911
Camacho-Pereira, J., Tarragó, M. G., Chini, C. C. S., Nin, V., Escande, C., Warner, G. M., Puranik, A. S., Schoon, R. A., Reid, J. M., Galina, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.006 · Cited by 901
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology
Malavasi, F., Deaglio, S., Funaro, A., Ferrero, E., Horenstein, A. L., Ortolan, E., Vaisitti, T., & Aydin, S. (2008) · Physiological Reviews · doi:10.1152/physrev.00035.2007 · Cited by 862
PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation
Bai, P., Cantó, C., Oudart, H., Brunyánszki, A., Cen, Y., Thomas, C., Yamamoto, H., Huber, A., Kiss, B., Houtkooper, R. H., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.004 · Cited by 837
NAD+ in Brain Aging and Neurodegenerative Disorders
Lautrup, S., Sinclair, D. A., Mattson, M. P., & Fang, E. F. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.001 · Cited by 790
Dilated Cardiomyopathy: Genetic Determinants and Mechanisms
McNally, E. M., & Mestroni, L. (2017) · Circulation Research · doi:10.1161/circresaha.116.309396 · Cited by 786
Metabolic Control of Longevity
López-Otín, C., Galluzzi, L., Freije, J. M. P., Madeo, F., & Kroemer, G. (2016) · Cell · doi:10.1016/j.cell.2016.07.031 · Cited by 753
Self-citationPuccio, H., Simon, D., Cossée, M., Criqui-Filipe, P., Tiziano, F., Melki, J., Hindelang, C., Matyas, R., Rustin, P., & Koenig, M. (2001) · Nature Genetics · doi:10.1038/84818 · Cited by 738
Defective Mitophagy in XPA via PARP-1 Hyperactivation and NAD+/SIRT1 Reduction
Fang, E. F., Scheibye-Knudsen, M., Brace, L. E., Kassahun, H., SenGupta, T., Nilsen, H., Mitchell, J. R., Croteau, D. L., & Bohr, V. A. (2014) · Cell · doi:10.1016/j.cell.2014.03.026 · Cited by 711
Bogan, K. L., & Brenner, C. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155443 · Cited by 707
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Trammell, S. A. J., Schmidt, M. S., Weidemann, B. J., Redpath, P., Jaksch, F., Dellinger, R. W., Li, Z., Abel, E. D., Migaud, M. E., & Brenner, C. (2016) · Nature Communications · doi:10.1038/ncomms12948 · Cited by 697
A Phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention
Chen, A. C., Martin, A. J., Choy, B., Fernández-Peñas, P., Dalziell, R. A., McKenzie, C. A., Scolyer, R. A., Dhillon, H. M., Vardy, J. L., Kricker, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506197 · Cited by 648
NAD+ homeostasis in health and disease
Katsyuba, E., Romani, M., Hofer, D., & Auwerx, J. (2020) · Nature Metabolism · doi:10.1038/s42255-019-0161-5 · Cited by 627
Martens, C. R., Denman, B. A., Mazzo, M. R., Armstrong, M. L., Reisdorph, N., McQueen, M. B., Chonchol, M., & Seals, D. R. (2018) · Nature Communications · doi:10.1038/s41467-018-03421-7 · Cited by 588
Quantitative Analysis of NAD Synthesis-Breakdown Fluxes
Liu, L., Su, X., Quinn, W. J., Hui, S., Krukenberg, K., Frederick, D. W., Redpath, P., Zhan, L., Chellappa, K., White, E., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.018 · Cited by 564
Wang, Z., Ying, Z., Bosy-Westphal, A., Zhang, J., Schautz, B., Later, W., Heymsfield, S. B., & Müller, M. J. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29885 · Cited by 546
Gale, E. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15786-3 · Cited by 534
Length-independent telomere damage drives post-mitotic cardiomyocyte senescence
Anderson, R., Lagnado, A., Maggiorani, D., Walaszczyk, A., Dookun, E., Chapman, J., Birch, J., Salmonowicz, H., Ogrodnik, M., Jurk, D., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100492 · Cited by 532
López-Otín, C., & Kroemer, G. (2021) · Cell · doi:10.1016/j.cell.2020.11.034 · Cited by 499
Self-citationSirtuins and NAD + in the Development and Treatment of Metabolic and Cardiovascular Diseases
Kane, A. E., & Sinclair, D. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.312498 · Cited by 487
Exploring and comparing adverse events between PARP inhibitors
LaFargue, C. J., Dal Molin, G. Z., Sood, A. K., & Coleman, R. L. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30786-1 · Cited by 487
Elhassan, Y. S., Kluckova, K., Fletcher, R. S., Schmidt, M. S., Garten, A., Doig, C. L., Cartwright, D. M., Oakey, L., Burley, C. V., Jenkinson, N., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.043 · Cited by 448
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Yoshino, M., Yoshino, J., Kayser, B. D., Patti, G. J., Franczyk, M. P., Mills, K. F., Sindelar, M., Pietka, T., Patterson, B. W., Imai, S.-I., et al. (2021) · Science · doi:10.1126/science.abe9985 · Cited by 439
Protective effects of sirtuins in cardiovascular diseases: from bench to bedside
Winnik, S., Auwerx, J., Sinclair, D. A., & Matter, C. M. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv290 · Cited by 422
Safety of high-dose nicotinamide: a review
Knip, M., Douek, I. F., Moore, W. P. T., Gillmor, H. A., McLean, A. E. M., Bingley, P. J., & Gale, E. A. M. (2000) · Diabetologia · doi:10.1007/s001250051536 · Cited by 422
Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages
Covarrubias, A. J., Kale, A., Perrone, R., Lopez-Dominguez, J. A., Pisco, A. O., Kasler, H. G., Schmidt, M. S., Heckenbach, I., Kwok, R., Wiley, C. D., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00305-3 · Cited by 420
Pillai, V. B., Sundaresan, N. R., Kim, G., Gupta, M., Rajamohan, S. B., Pillai, J. B., Samant, S., Ravindra, P. V., Isbatan, A., & Gupta, M. P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077271 · Cited by 419
Extracellular vesicle-contained eNAMPT delays aging and extends lifespan in mice
Yoshida, M., Satoh, A., Lin, J. B., Mills, K. F., Sasaki, Y., Rensing, N., Wong, M., Apte, R. S., & Imai, S.-I. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.05.015 · Cited by 407
Picciotto, N. E., Gano, L. B., Johnson, L. C., Martens, C. R., Sindler, A. L., Mills, K. F., Imai, S., & Seals, D. R. (2016) · Aging Cell · doi:10.1111/acel.12461 · Cited by 396
Pillai, J. B., Isbatan, A., Imai, S.-I., & Gupta, M. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506162200 · Cited by 391
Tarragó, M. G., Chini, C. C. S., Kanamori, K. S., Warner, G. M., Caride, A., de Oliveira, G. C., Rud, M., Samani, A., Hein, K. Z., Huang, R., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.016 · Cited by 384
NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
Ratajczak, J., Joffraud, M., Trammell, S. A. J., Ras, R., Canela, N., Boutant, M., Kulkarni, S. S., Rodrigues, M., Redpath, P., Migaud, M. E., et al. (2016) · Nature Communications · doi:10.1038/ncomms13103 · Cited by 378
The role of sirtuins in cardiac disease
Matsushima, S., & Sadoshima, J. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00053.2015 · Cited by 375
De novo NAD+ biosynthetic impairment in acute kidney injury in humans
Poyan Mehr, A., Tran, M. T., Ralto, K. M., Leaf, D. E., Washco, V., Messmer, J., Lerner, A., Kher, A., Kim, S. H., Khoury, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0138-z · Cited by 370
Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal Muscle
Frederick, D. W., Loro, E., Liu, L., Davila, A., Chellappa, K., Silverman, I. M., Quinn, W. J., Gosai, S. J., Tichy, E. D., Davis, J. G., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.005 · Cited by 367
Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy
Diguet, N., Trammell, S. A. J., Tannous, C., Deloux, R., Piquereau, J., Mougenot, N., Gouge, A., Gressette, M., Manoury, B., Blanc, J., et al. (2018) · Circulation · doi:10.1161/circulationaha.116.026099 · Cited by 358
A high-fat diet and NAD(+) activate Sirt1 to rescue premature aging in Cockayne syndrome
Scheibye-Knudsen, M., Mitchell, S. J., Fang, E. F., Iyama, T., Ward, T., Wang, J., Dunn, C. A., Singh, N., Veith, S., Hasan-Olive, M. M., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.005 · Cited by 352
CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels
Chini, C. C. S., Peclat, T. R., Warner, G. M., Kashyap, S., Espindola-Netto, J. M., de Oliveira, G. C., Gomez, L. S., Hogan, K. A., Tarragó, M. G., Puranik, A. S., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00298-z · Cited by 349
Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice
Mitchell, S. J., Bernier, M., Aon, M. A., Cortassa, S., Kim, E. Y., Fang, E. F., Palacios, H. H., Ali, A., Navas-Enamorado, I., Di Francesco, A., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.001 · Cited by 338
Normalization of NAD + Redox Balance as a Therapy for Heart Failure
Lee, C. F., Chavez, J. D., Garcia-Menendez, L., Choi, Y., Roe, N. D., Chiao, Y. A., Edgar, J. S., Goo, Y. A., Goodlett, D. R., Bruce, J. E., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022495 · Cited by 336
Arimura, T., Helbling-Leclerc, A., Massart, C., Varnous, S., Niel, F., Lacène, E., Fromes, Y., Toussaint, M., Mura, A.-M., Keller, D. I., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi017 · Cited by 330
Pathways and Subcellular Compartmentation of NAD Biosynthesis in Human Cells
Nikiforov, A., Dölle, C., Niere, M., & Ziegler, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213298 · Cited by 326
Pacher, P., & Szabó, C. (2007) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2007.00018.x · Cited by 316
SLC25A51 is a mammalian mitochondrial NAD(+) transporter
Luongo, T. S., Eller, J. M., Lu, M.-J., Niere, M., Raith, F., Perry, C., Bornstein, M. R., Oliphint, P., Wang, L., McReynolds, M. R., et al. (2020) · Nature · doi:10.1038/s41586-020-2741-7 · Cited by 308
Hamdani, N., Franssen, C., Lourenço, A., Falcão-Pires, I., Fontoura, D., Leite, S., Plettig, L., López, B., Ottenheijm, C. A., Becher, P. M., et al. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.113.000539 · Cited by 307
Yamamoto, T., Byun, J., Zhai, P., Ikeda, Y., Oka, S., & Sadoshima, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098972 · Cited by 305
NAD+ homeostasis in renal health and disease
Ralto, K. M., Rhee, E. P., & Parikh, S. M. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0216-6 · Cited by 291
Evolving concepts in NAD+ metabolism
Chini, C. C. S., Zeidler, J. D., Kashyap, S., Warner, G., & Chini, E. N. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.04.003 · Cited by 288
Slc12a8 is a nicotinamide mononucleotide transporter
Grozio, A., Mills, K. F., Yoshino, J., Bruzzone, S., Sociali, G., Tokizane, K., Lei, H. C., Cunningham, R., Sasaki, Y., Migaud, M. E., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-018-0009-4 · Cited by 287
Hsu, C.-P., Oka, S., Shao, D., Hariharan, N., & Sadoshima, J. (2009) · Circulation Research · doi:10.1161/circresaha.109.203703 · Cited by 284
Dollerup, O. L., Christensen, B., Svart, M., Schmidt, M. S., Sulek, K., Ringgaard, S., Stødkilde-Jørgensen, H., Møller, N., Brenner, C., Treebak, J. T., et al. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy132 · Cited by 282
Tarantini, S., Valcarcel-Ares, M. N., Toth, P., Yabluchanskiy, A., Tucsek, Z., Kiss, T., Hertelendy, P., Kinter, M., Ballabh, P., Süle, Z., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101192 · Cited by 282
Pirinen, E., Auranen, M., Khan, N. A., Brilhante, V., Urho, N., Pessia, A., Hakkarainen, A., Kuula, J., Heinonen, U., Schmidt, M. S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.008 · Cited by 278
Airhart, S. E., Shireman, L. M., Risler, L. J., Anderson, G. D., Nagana Gowda, G. A., Raftery, D., Tian, R., Shen, D. D., & O’Brien, K. D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186459 · Cited by 259
Hong, S., Moreno-Navarrete, J. M., Wei, X., Kikukawa, Y., Tzameli, I., Prasad, D., Lee, Y., Asara, J. M., Fernandez-Real, J. M., Maratos-Flier, E., et al. (2015) · Nature Medicine · doi:10.1038/nm.3882 · Cited by 257
Supplemental vitamins and minerals for CVD prevention and treatment
Jenkins, D. J. A., Spence, J. D., Giovannucci, E. L., Kim, Y.-I., Josse, R., Vieth, R., Blanco Mejia, S., Viguiliouk, E., Nishi, S., Sahye-Pudaruth, S., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.020 · Cited by 251
Barbosa, M. T. P., Soares, S. M., Novak, C. M., Sinclair, D., Levine, J. A., Aksoy, P., & Chini, E. N. (2007) · The FASEB Journal · doi:10.1096/fj.07-8290com · Cited by 248
Bacteria Boost Mammalian Host NAD Metabolism by Engaging the Deamidated Biosynthesis Pathway
Shats, I., Williams, J. G., Liu, J., Makarov, M. V., Wu, X., Lih, F. B., Deterding, L. J., Lim, C., Xu, X., Randall, T. A., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.02.001 · Cited by 242
NAD + Repletion Reverses Heart Failure With Preserved Ejection Fraction
Tong, D., Schiattarella, G. G., Jiang, N., Altamirano, F., Szweda, P. A., Elnwasany, A., Lee, D. I., Yoo, H., Kass, D. A., Szweda, L. I., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.317046 · Cited by 239
Zingarelli, B. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00137-5 · Cited by 224
Digby, J. E., Martinez, F., Jefferson, A., Ruparelia, N., Chai, J., Wamil, M., Greaves, D. R., & Choudhury, R. P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.241836 · Cited by 221
Role of NAD+ and mitochondrial sirtuins in cardiac and renal diseases
Hershberger, K. A., Martin, A. S., & Hirschey, M. D. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.5 · Cited by 218
Stromsdorfer, K. L., Yamaguchi, S., Yoon, M. J., Moseley, A. C., Franczyk, M. P., Kelly, S. C., Qi, N., Imai, S.-I., & Yoshino, J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.027 · Cited by 213
Nicotinamide for the treatment of heart failure with preserved ejection fraction
Abdellatif, M., Trummer-Herbst, V., Koser, F., Durand, S., Adão, R., Vasques-Nóvoa, F., Freundt, J. K., Voglhuber, J., Pricolo, M.-R., Kasa, M., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd7064 · Cited by 212
Self-citationBoosting NAD level suppresses inflammatory activation of PBMCs in heart failure
Zhou, B., Wang, D. D.-H., Qiu, Y., Airhart, S., Liu, Y., Stempien-Otero, A., O’Brien, K. D., & Tian, R. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138538 · Cited by 209
NAD and the aging process: role in life, death and everything in between
Chini, C. C. S., Tarragó, M. G., & Chini, E. N. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.003 · Cited by 208
Hara, N., Yamada, K., Shibata, T., Osago, H., Hashimoto, T., & Tsuchiya, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610357200 · Cited by 205
MCART1/SLC25A51 is required for mitochondrial NAD transport
Kory, N., uit de Bos, J., van der Rijt, S., Jankovic, N., Güra, M., Arp, N., Pena, I. A., Prakash, G., Chan, S. H., Kunchok, T., et al. (2020) · Science Advances · doi:10.1126/sciadv.abe5310 · Cited by 205
Irie, J., Inagaki, E., Fujita, M., Nakaya, H., Mitsuishi, M., Yamaguchi, S., Yamashita, K., Shigaki, S., Ono, T., Yukioka, H., et al. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej19-0313 · Cited by 191
Fasting and refeeding differentially regulate NLRP3 inflammasome activation in human subjects
Traba, J., Kwarteng-Siaw, M., Okoli, T. C., Li, J., Huffstutler, R. D., Bray, A., Waclawiw, M. A., Han, K., Pelletier, M., Sauve, A. A., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83260 · Cited by 180
CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
Morandi, F., Horenstein, A. L., Costa, F., Giuliani, N., Pistoia, V., & Malavasi, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02722 · Cited by 176
Williams, L. M., Campbell, F. M., Drew, J. E., Koch, C., Hoggard, N., Rees, W. D., Kamolrat, T., Thi Ngo, H., Steffensen, I.-L., Gray, S. R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106159 · Cited by 175
Hong, W., Mo, F., Zhang, Z., Huang, M., & Wei, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00246 · Cited by 174
McReynolds, M. R., Chellappa, K., & Baur, J. A. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110888 · Cited by 163
Zhang, D., Hu, X., Li, J., Liu, J., Baks-te Bulte, L., Wiersma, M., Malik, N.-U.-A., van Marion, D. M. S., Tolouee, M., Hoogstra-Berends, F., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09014-2 · Cited by 162
Remie, C. M., Roumans, K. H., Moonen, M. P., Connell, N. J., Havekes, B., Mevenkamp, J., Lindeboom, L., de Wit, V. H., van de Weijer, T., Aarts, S. A., et al. (2020) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa072 · Cited by 160
Metabolic Profiling of Alternative NAD Biosynthetic Routes in Mouse Tissues
Mori, V., Amici, A., Mazzola, F., Di Stefano, M., Conforti, L., Magni, G., Ruggieri, S., Raffaelli, N., & Orsomando, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113939 · Cited by 158
Libri, V., Yandım, C., Athanasopoulos, S., Loyse, N., Natisvili, T., Law, P. P., Chan, P. K., Mohammad, T., Mauri, M., Tam, K. T., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60382-2 · Cited by 158
Henning, R. J., Bourgeois, M., & Harbison, R. D. (2018) · Cardiovascular Toxicology · doi:10.1007/s12012-018-9462-2 · Cited by 158
Yang, S. J., Choi, J. M., Kim, L., Park, S. E., Rhee, E., Lee, W., Oh, K. W., Park, S. W., & Park, C.-Y. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.09.004 · Cited by 146
Dollerup, O. L., Chubanava, S., Agerholm, M., Søndergård, S. D., Altıntaş, A., Møller, A. B., Høyer, K. F., Ringgaard, S., Stødkilde‐Jørgensen, H., Lavery, G. G., et al. (2020) · The Journal of Physiology · doi:10.1113/jp278752 · Cited by 145
Gorski, P. A., Jang, S. P., Jeong, D., Lee, A., Lee, P., Oh, J. G., Chepurko, V., Yang, D. K., Kwak, T. H., Eom, S. H., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.313865 · Cited by 140
Valdivia, C. R., Ueda, K., Ackerman, M. J., & Makielski, J. C. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00513.2009 · Cited by 139
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Buqué, A., Bloy, N., Perez-Lanzón, M., Iribarren, K., Humeau, J., Pol, J. G., Levesque, S., Mondragon, L., Yamazaki, T., Sato, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17644-0 · Cited by 138
Self-citationFletcher, R. S., Ratajczak, J., Doig, C. L., Oakey, L. A., Callingham, R., Xavier, G. D. S., Garten, A., Elhassan, Y., Redpath, P., Migaud, M. E., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.05.011 · Cited by 134
Martin, A. S., Abraham, D. M., Hershberger, K. A., Bhatt, D. P., Mao, L., Cui, H., Liu, J., Liu, X., Muehlbauer, M. J., Grimsrud, P. A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93885 · Cited by 128
Cardiac Na + Current Regulation by Pyridine Nucleotides
Liu, M., Sanyal, S., Gao, G., Gurung, I. S., Zhu, X., Gaconnet, G., Kerchner, L. J., Shang, L. L., Huang, C. L.-H., Grace, A. A., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.197277 · Cited by 124
Alano, C. C., Tran, A., Tao, R., Ying, W., Karliner, J. S., & Swanson, R. A. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21479 · Cited by 123
Epistasis-driven identification of SLC25A51 as a regulator of human mitochondrial NAD import
Girardi, E., Agrimi, G., Goldmann, U., Fiume, G., Lindinger, S., Sedlyarov, V., Srndic, I., Gürtl, B., Agerer, B., Kartnig, F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19871-x · Cited by 123
Yamamura, S., Izumiya, Y., Araki, S., Nakamura, T., Kimura, Y., Hanatani, S., Yamada, T., Ishida, T., Yamamoto, M., Onoue, Y., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13357 · Cited by 121
Zou, Y., Wang, A., Huang, L. Z., Zhu, X., Hu, Q., Zhang, Y., Chen, X., Li, F., Wang, Q., Wang, H., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.02.017 · Cited by 119
Harrison, D. E., Strong, R., Reifsnyder, P. C., Kumar, N., Fernández, E., Flurkey, K., Javors, M. A., Lopez‐Cruzan, M., Macchiarini, F., Nelson, J. F., et al. (2021) · Aging Cell · doi:10.1111/acel.13328 · Cited by 118
NAD+ flux is maintained in aged mice despite lower tissue concentrations
McReynolds, M. R., Chellappa, K., Chiles, E., Jankowski, C., Shen, Y., Chen, L., Descamps, H. C., Mukherjee, S., Bhat, Y. R., Lingala, S. R., et al. (2021) · Cell Systems · doi:10.1016/j.cels.2021.09.001 · Cited by 112
Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment
Jenkins, D. J. A., Spence, J. D., Giovannucci, E. L., Kim, Y.-I., Josse, R. G., Vieth, R., Sahye-Pudaruth, S., Paquette, M., Patel, D., Blanco Mejia, S., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.09.619 · Cited by 110
D’Andrea, E., Hey, S. P., Ramirez, C. L., & Kesselheim, A. S. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.2224 · Cited by 100
Pillai, V. B., Sundaresan, N. R., Kim, G., Samant, S., Moreno-Vinasco, L., Garcia, J. G. N., & Gupta, M. P. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00468.2012 · Cited by 97
Szántó, M., & Bai, P. (2020) · Genes & Development · doi:10.1101/gad.334284.119 · Cited by 97
Mitochondrial dysfunction causing cardiac sodium channel downregulation in cardiomyopathy
Liu, M., Gu, L., Sulkin, M. S., Liu, H., Jeong, E.-M., Greener, I. D., Xie, A., Efimov, I. R., & Dudley, S. C. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.10.011 · Cited by 95
CD38 promotes angiotensin II‐induced cardiac hypertrophy
Guan, X., Hong, X., Zhao, N., Liu, X., Xiao, Y., Chen, T., Deng, L., Wang, X., Wang, J., Ji, G., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13076 · Cited by 90
Guan, X., Liu, X., Hong, X., Zhao, N., Xiao, Y., Wang, L.-F., Tang, L., Jiang, K., Qian, Y., Deng, K., et al. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7410257 · Cited by 90
Regulation of Calcium Signaling by the Second Messenger Cyclic Adenosine Diphosphoribose (cADPR)
Guse, A. H. (2004) · Current Molecular Medicine · doi:10.2174/1566524043360771 · Cited by 85
Niacin Inhibits Vascular Inflammation via the Induction of Heme Oxygenase-1
Wu, B. J., Chen, K., Barter, P. J., & Rye, K. (2011) · Circulation · doi:10.1161/circulationaha.111.053108 · Cited by 85
Sirtuin 1 regulates cardiac electrical activity by deacetylating the cardiac sodium channel
Vikram, A., Lewarchik, C. M., Yoon, J., Naqvi, A., Kumar, S., Morgan, G. M., Jacobs, J. S., Li, Q., Kim, Y., Kassan, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4284 · Cited by 85
Tannous, C., Booz, G. W., Altara, R., Muhieddine, D. H., Mericskay, M., Refaat, M. M., & Zouein, F. A. (2020) · Acta Physiologica · doi:10.1111/apha.13551 · Cited by 82
Extreme Acetylation of the Cardiac Mitochondrial Proteome Does Not Promote Heart Failure
Davidson, M. T., Grimsrud, P. A., Lai, L., Draper, J. A., Fisher‐Wellman, K. H., Narowski, T. M., Abraham, D., Koves, T. R., Kelly, D. P., & Muoio, D. M. (2020) · Circulation Research · doi:10.1161/circresaha.120.317293 · Cited by 79
Hosseini, L., Vafaee, M. S., & Badalzadeh, R. (2019) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248419882002 · Cited by 76
PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axis
Waldman, M., Nudelman, V., Shainberg, A., Abraham, N. G., Kornwoski, R., Aravot, D. J., Arad, M., & Hochhauser, E. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.10.003 · Cited by 75
NAD + Redox Imbalance in the Heart Exacerbates Diabetic Cardiomyopathy
Chiao, Y. A., Chakraborty, A. D., Light, C. M., Tian, R., Sadoshima, J., Shi, X., Gu, H., & Lee, C. F. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.008170 · Cited by 69
Lin, W. K., Bolton, E. L., Cortopassi, W. A., Wang, Y., O’Brien, F., Maciejewska, M., Jacobson, M. P., Garnham, C., Ruas, M., Parrington, J., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.789347 · Cited by 67
Kropotov, A., Kulikova, V., Nerinovski, K., Yakimov, A. P., Svetlova, M., Solovjeva, L., Sudnitsyna, J. S., Migaud, M. E., Khodorkovskiy, M., Ziegler, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031391 · Cited by 63
Cox, M. J., Sood, H. S., Hunt, M. J., Chandler, D., Henegar, J. R., Aru, G. M., & Tyagi, S. C. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00483.2001 · Cited by 62
Nampt Potentiates Antioxidant Defense in Diabetic Cardiomyopathy
Oka, S., Byun, J., Huang, C.-Y., Imai, N., Ralda, G., Zhai, P., Xu, X., Kashyap, S., Warren, J. S., Maschek, J. A., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.317943 · Cited by 62
Leite, S., Oliveira‐Pinto, J., Tavares-Silva, M., Abdellatif, M., Fontoura, D., Falcão‐Pires, I., Leite-Moreira, A. F., & Lourenço, A. P. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00076.2015 · Cited by 61
Self-citationVignier, N., Chatzifrangkeskou, M., Rodríguez, B. M., Mericskay, M., Mougenot, N., Wahbi, K., Bonne, G., & Muchir, A. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy278 · Cited by 60
Wu, K., Li, B., Lin, Q., Xu, W., Zuo, W., Li, J., Liu, N., Tu, T., Zhang, B., Xiao, Y., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119299 · Cited by 60
Horimatsu, T., Blomkalns, A. L., Ogbi, M., Moses, M. M., Kim, D. S., Patel, S. Y., Gilreath, N., Reid, L. E., Benson, T. W., Pye, J., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz303 · Cited by 59
Zhang, Y.-J., Zhang, M., Zhao, X., Shi, K., Ye, M., Tian, J., Guan, S., Ying, W., & Qu, X. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-0817-z · Cited by 56
Zhou, L., Zhang, S., Bolor-Erdene, E., Wang, L., Ding, T., & Mei, Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1974265 · Cited by 56
Hamdani, N., Costantino, S., Mügge, A., Lebeche, D., Tschöpe, C., Thum, T., & Paneni, F. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab197 · Cited by 56
Niacin: another look at an underutilized lipid-lowering medication
Creider, J. C., Hegele, R. A., & JOY, T. R. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.22 · Cited by 55
Zhang, Y., Wang, B., Fu, X., Guan, S., Han, W., Zhang, J., Gan, Q., Fang, W., Ying, W., & Qu, X. (2016) · Europe PMC (PubMed Central) · Cited by 55
A biosensor for measuring NAD+ levels at the point of care
Yu, Q., Pourmandi, N., Xue, L., Gondrand, C., Fabritz, S., Bardy, D., Patiny, L., Katsyuba, E., Auwerx, J. H., & Johnsson, K. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0151-7 · Cited by 55
da Silva, R., Fraga-Silva, R. A., Steffens, S., Fabre, M., Bauer, I., Caffa, I., Magnone, M., Sociali, G., Quercioli, A., Pelli, G., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-07-0531 · Cited by 53
Both gain and loss of Nampt function promote pressure overload-induced heart failure
Byun, J., Oka, S., Imai, N., Huang, C.-Y., Ralda, G., Zhai, P., Ikeda, Y., Ikeda, S., & Sadoshima, J. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00222.2019 · Cited by 53
NAD+ and cardiovascular diseases
Lin, Q., Zuo, W., Liu, Y., Wu, K., & Liu, Q. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.01.012 · Cited by 51
Liu, L., Wang, Q., Zhao, B., Wu, Q., & Wang, P. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172520 · Cited by 49
Sukhodub, A., Du, Q., Jovanović, S., et al. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.01.008 · Cited by 48
Myocardial Ischemic Preconditioning in Rodents Is Dependent on Poly (ADP-Ribose) Synthetase
Liaudet, L., Yang, Z., Affar, E. B., & Szabó, C. (2001) · Molecular Medicine · doi:10.1007/bf03402187 · Cited by 48
Bermudez, B., Dahl, T. B., Medina, I., Groeneweg, M., Holm, S., Montserrat-de la Paz, S., Rousch, M., Otten, J., Herias, V., Varela, L. M., et al. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.308187 · Cited by 47
Wang, L.-F., Huang, C., Xiao, Y., Guan, X., Wang, X., Cao, Q. N., Liu, Y., Huang, X., Deng, L., Deng, K., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492651 · Cited by 47
Han, X., Bao, X., Lou, Q., Xie, X. M., Zhang, M., Zhou, S., Guo, H., Jiang, G., & Shi, Q. (2019) · PeerJ · doi:10.7717/peerj.7568 · Cited by 44
Boslett, J., Reddy, N., Alzarie, Y. A., & Zweier, J. L. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.254557 · Cited by 43
SIRT3 is required for liver regeneration but not for the beneficial effect of nicotinamide riboside
Mukherjee, S., Mo, J., Paolella, L. M., Perry, C. E., Toth, J., Hugo, M., Chu, Q., Tong, Q., Chellappa, K., & Baur, J. A. (2021) · JCI Insight · doi:10.1172/jci.insight.147193 · Cited by 43
Boslett, J. J., Helal, M., Chini, E. N., & Zweier, J. L. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.02.015 · Cited by 42
Chiang, S.-H., Harrington, W. W., Luo, G., Milliken, N. O., Ulrich, J. C., Chen, J., Rajpal, D. K., Qian, Y., Carpenter, T. Y., Murray, R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134927 · Cited by 41
Nie, H., Zhang, Y., Yu, H., Xiao, H., Li, T., & Yang, Q. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1886198 · Cited by 37
CD38: A Potential Therapeutic Target in Cardiovascular Disease
Zuo, W., Liu, N., Zeng, Y., Liu, Y., Li, B., Wu, K., Xiao, Y., & Liu, Q. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07007-8 · Cited by 36
Ördög, K., Horváth, O., Erős, K., Bruszt, K., Toth, S., Kovács, D., Kálmán, N., Radnai, B., Deres, L., Gallyas, F., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118936 · Cited by 36
Kong, Y., Li, G., Zhang, W., Hua, X., Zhou, C., Xu, T., Li, Z., Wang, P., & Miao, C. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0207-3 · Cited by 34
Wang, H., Yang, X. F., Yang, Q., Gong, L., Xu, H., & Wu, Z. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.091 · Cited by 29
Zhang, X., Li, L., Zhang, Q., Wei, Q., Lin, J., Jia, J., Zhang, J., Yan, T., Lv, Y., Jiang, X., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00191 · Cited by 28
Tong, D., Zhang, D., Fei, X., Teng, M., Jiang, X., Hou, J., Zhang, Q., & Huang, Y. (2012) · Pharmacology · doi:10.1159/000338628 · Cited by 27
Zhai, X., Han, W., Wang, M., Guan, S., & Qu, X. (2019) · PubMed · Cited by 27
Philpott, A. C., Hubacek, J., Sun, Y., Hillard, D., & Anderson, T. J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.10.067 · Cited by 26
Modulation of the cardiac sodium channel NaV1.5 peak and late currents by NAD+ precursors
Matasic, D. S., Yoon, J., McLendon, J. M., et al. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.01.013 · Cited by 26
Specific binding and uptake of extracellular nicotinamide in human leukemic k-562 cells
Olsson, A. R., Olofsson, T., & Pero, R. W. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90270-7 · Cited by 24
Selective inhibitors of cardiac ADPR cyclase as novel anti-arrhythmic compounds
Kannt, A., Sicka, K., Kroll, K., Kadereit, D., & Gögelein, H. (2012) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-012-0750-2 · Cited by 23
the EFACTS or NICOFA study group, Reetz, K., Hilgers, R.-D., Isfort, S., Dohmen, M., Didszun, C., Fedosov, K., Kistermann, J., Mariotti, C., Dürr, A., et al. (2019) · Neurological Research and Practice · doi:10.1186/s42466-019-0038-9 · Cited by 22
de Castro, J. M., Assumpção, J. A. F., Stein, D. J., Ströher, R., da Silva, L. S., Caumo, W., Carraro, C. C., Araújo, A. S. D. R., & Torres, I. L. D. S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118596 · Cited by 21
Huynh, P. K., Wilder, J., Hiller, S., Hagaman, J. R., Takahashi, N., Maeda-Smithies, N., & Li, F. (2020) · Journal of Experimental Nephrology · doi:10.46439/nephrology.1.001 · Cited by 14
Abdellatif, M., Leite, S., Alaa, M. H., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00399.2015 · Cited by 13
Self-citationSukoyan, G. V., & Кавадзе, И. К. (2008) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-008-0268-2 · Cited by 12
NAD+ metabolism and cardiometabolic health: the human evidence
Abdellatif, M., & Baur, J. A. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab212 · Cited by 12
Self-citationAutophagy promotes longevity—except in the presence of ‘leaky’ mitochondria
Abdellatif, M. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz224 · Cited by 5
Self-citation
Research works printed but not linked: 4
- 10.1007/s10517-005-0208-3 · doi:10.1007/s10517-005-0208-3
- 10.1097/FJC.0b013e318292c663 · doi:10.1097/fjc.0b013e318292c663
- 10.1161/res.127.suppl_1.452 · doi:10.1161/res.127.suppl_1.452
- 10.1016/j.hrthm.2016.12.026 · doi:10.1016/j.hrthm.2016.12.026
Cited by
Atherosclerosis: Recent developments
Björkegren, J. L. M., & Lusis, A. J. (2022) · Cell · doi:10.1016/j.cell.2022.04.004 · Cited by 1,249
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 399
Hallmarks of cardiovascular ageing
Abdellatif, M., Rainer, P. P., Sedej, S., & Kroemer, G. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00881-3 · Cited by 274
Self-citationAlegre, G. F. S., & Pastore, G. M. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00475-y · Cited by 101
Endothelial cell metabolism in cardiovascular physiology and disease
Pasut, A., Lama, E., Van Craenenbroeck, A. H., Kroon, J., & Carmeliet, P. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01162-x · Cited by 74
Metadata
- Authors
- Abdellatif, M., Sedej, S., & Kroemer, G.
- Venue
- Circulation
- Published
- 2021-11-30
- Volume
- 144
- Issue
- 22
- Pages
- 1795-1817
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W3216175734
- Cited by
- 255
- References
- 174
- FWCI
- 13.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.